文献速递妇科

子宫动脉栓塞术与子宫肌瘤剔除术治疗子宫肌瘤女性的比较:系统评价与荟萃分析

Uterine artery embolization vs myomectomy for the management of women with uterine leiomyomas: a systematic review and meta-analysis.
PubMed 文献 · Am J Obstet Gynecol · 2024-01-26

本系统评价与荟萃分析纳入6项随机对照试验,比较子宫动脉栓塞术与子宫肌瘤剔除术对绝经前子宫肌瘤女性生活质量、再干预、妊娠结局及围手术期并发症的影响。结果显示两种干预在生活质量上可能无差异,但子宫肌瘤剔除术可能与再干预风险降低及再干预时间延长相关,围手术期严重不良事件无差异,证据确定性低至极低。

要点

  • 子宫肌瘤剔除术可能与再干预风险降低相关(RR 0.32,95%CI 0.15-0.69,低确定性证据)。
  • 子宫肌瘤剔除术可能与再干预时间延长相关(HR 0.41,95%CI 0.22-0.77,低确定性证据)。
  • 两种干预在生活质量上可能无差异(SMD 0.05,95%CI -0.38-0.48,极低确定性证据)。

核心结论

  • 在绝经前子宫肌瘤女性中,与子宫肌瘤剔除术相比,子宫动脉栓塞术可能与再干预率增加及再干预时间缩短相关。
  • 证据提示两种干预在围手术期并发症方面无差异。
  • 子宫动脉栓塞术对生活质量和成功妊娠可能无影响,但证据非常不确定。

研究设计与样本

  • 系统评价与荟萃分析,检索PubMed和Cochrane对照试验中心注册库从建库至2023年1月。
  • 纳入比较子宫动脉栓塞术与子宫肌瘤剔除术治疗绝经前子宫肌瘤女性的随机对照试验,共纳入6项随机对照试验。
  • 主要结局为生活质量,次要结局包括再干预率及时间、成功妊娠、死产和流产、分娩时剖宫产及围手术期并发症。
  • 采用GRADE方法评估证据确定性。

主要发现

  • 生活质量:子宫动脉栓塞术与子宫肌瘤剔除术相比,标准均数差0.05(95%CI -0.38至0.48;I²=92%;极低确定性证据),提示 little to no difference。
  • 敏感性分析仅纳入对照组为子宫肌瘤剔除术的随机对照试验,显示子宫肌瘤剔除术组生活质量更优(标准均数差-0.32;95%CI -0.49至-0.15;I²=15%)。
  • 再干预风险:子宫肌瘤剔除术可能与再干预风险降低相关(风险比0.32;95%CI 0.15-0.69;I²=60%;低确定性证据)。
  • 再干预时间:子宫肌瘤剔除术可能与因复发导致再干预的时间间隔更长相关(风险比0.41;95%CI 0.22-0.77;I²=77%;低确定性证据)。
  • 围手术期严重不良事件:两种干预无差异(相对风险4.13;95%CI 0.44-39.20;I²=0%;低确定性证据)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study aimed to investigate whether uterine artery embolization offers a better quality of life than myomectomy in premenopausal women diagnosed with leiomyomas of the uterus. DATA SOURCES: A literature search was performed using the electronic databases of PubMed and Cochrane Central Register of Controlled Trials from inception to January 2023. STUDY ELIGIBILITY CRITERIA: Randomized controlled trials comparing uterine artery embolization with myomectomy in women of premenopausal age suffering from uterine leiomyomas were considered. METHODS: The primary outcome was quality of life. The secondary outcomes were reintervention rate and timing, successful pregnancy, stillbirth and miscarriage, cesarean delivery on delivery, and perioperative morbidity. Moreover, time-to-event and standard pairwise meta-analyses were performed, as appropriate. The certainty of the evidence was assessed in line with the Grading of Recommendations, Assessment, Development, and Evaluations methodology. RESULTS: A total of 6 randomized controlled trials met our inclusion criteria. The meta-analysis suggested little to no difference in terms of quality of life between uterine artery embolization and myomectomy (standard mean difference, 0.05; 95% confidence interval, -0.38 to 0.48; I2=92%; very low certainty of evidence). Sensitivity analysis, including randomized controlled trials, which included solely myomectomy procedures in the control arm, demonstrated better quality of life for women treated with myomectomy (standard mean difference, -0.32; 95% confidence interval, -0.49 to -0.15; I2=15%). Concerning reintervention, myomectomy was likely associated with a decreased risk of future reintervention (risk ratio, 0.32; 95% confidence interval, 0.15-0.69; I2=60%; low certainty of evidence) and a more prolonged time interval since a potential reintervention because of recurrence than uterine artery embolization (hazard ratio, 0.41; 95% confidence interval, 0.22-0.77; I2=77%; low certainty of evidence). No difference was found between the 2 interventions concerning severe perioperative adverse events (relative risk, 4.13; 95% confidence interval, 0.44-39.20; I2=0%; low certainty of evidence). CONCLUSION: Uterine artery embolization is likely associated with increased reintervention rates and less time to reintervention compared with myomectomy in premenopausal women diagnosed with uterine leiomyomas. Evidence suggests no difference between the 2 interventions regarding perioperative morbidity. Uterine artery embolization may exert no effect on quality of life and successful pregnancy; however, the evidence is very uncertain.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Tzanis AA, Antoniou SA, Gkegkes ID, et al. Uterine artery embolization vs myomectomy for the management of women with uterine leiomyomas: a systematic review and meta-analysis. Am J Obstet Gynecol. 2024. PMID: 38280434. doi:10.1016/j.ajog.2024.01.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。